<DOC>
	<DOCNO>NCT01052597</DOCNO>
	<brief_summary>There evidence association insulin resistance prolong hyperinsulinemia hyperglycemia Type 2 diabetic patient . This trigger oxidative stress system via reactive oxygen specie ( ROS ) lead high level Nitric oxide . This contribute significant change blood vessel could end complication cardiovascular disease increase mortality rate type 2 diabetic patient . The purpose present study examine effectiveness curcumin type 2 diabetic patient reduction atherosclerosis event examine pulse-wave velocity ( PWV ) plasma high-sensitivity C-reactive protein ( CRP ) test blood sugar lowering , glycosylated hemoglobin ( HBA1c ) , lipid profile , insulin resistance .</brief_summary>
	<brief_title>Curcumin Type 2 Diabetic Patients</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Cardiovascular Abnormalities</mesh_term>
	<mesh_term>Curcumin</mesh_term>
	<criteria>Diabetic patient age 35 year old use insulin first 5 year treatment diagnose ( without symptom list follow inclusion criterion ) Patient hyperlipidemia ( Cholesterol ≥ 200 mg/dl , TG ≥ 150 mg/dl , LDL ≥ 100 mg/dl HDL ≥ 35 mg/dl ) Patient hypertension ( Blood pressure ≥ 130/85 mmHg take hypertensive drug ) Obesity ( BMI ≥ 25 ) Current diagnosis secondary peripheral arterial disease ( PAD ) ( except list inclusion criterion item 14 ) Current diagnosis cardiovascular disease , i.e. , coronary arterial disease cerebrovascular disease Current diagnosis end stage renal function serum creatinine &gt; 2.0 mg/dl renal dialysis Current diagnosis cirrhosis ALT ≥ 3 time normal range</criteria>
	<gender>All</gender>
	<minimum_age>35 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>August 2007</verification_date>
	<keyword>Type 2 diabetes</keyword>
	<keyword>Metabolic syndrome</keyword>
	<keyword>cardiovascular risk</keyword>
</DOC>